Generated by DeepSeek V3.2| NRRL 1951 | |
|---|---|
| Name | NRRL 1951 |
| Domain | Bacteria |
| Phylum | Actinomycetota |
| Class | Actinomycetia |
| Order | Streptomycetales |
| Family | Streptomycetaceae |
| Genus | Streptomyces |
| Species | Streptomyces griseus |
| Binomial | Streptomyces griseus |
NRRL 1951. This strain is a historically significant isolate of the filamentous bacterium Streptomyces griseus, renowned as the original source of the antibiotic streptomycin. Its discovery in the mid-20th century marked a pivotal advancement in the treatment of tuberculosis and other Gram-negative bacterial infections. The strain is maintained in the Agricultural Research Service Culture Collection, part of the United States Department of Agriculture.
The strain was first isolated from a soil sample collected by a team led by Selman Waksman at Rutgers University. This research was part of a systematic screening program for antimicrobial agents produced by soil-dwelling actinomycetes. The successful isolation and subsequent fermentation studies demonstrated potent activity against several pathogens, including Mycobacterium tuberculosis. This work directly led to the large-scale production of streptomycin by Merck & Co., revolutionizing chemotherapy. The discovery earned Selman Waksman the Nobel Prize in Physiology or Medicine in 1952.
NRRL 1951 is classified within the genus Streptomyces, a group known for its complex life cycle and prolific secondary metabolism. It belongs to the species Streptomyces griseus, as confirmed through extensive phenotypic characterization and later 16S ribosomal RNA gene sequencing. The strain's taxonomic placement links it to other industrially important species like Streptomyces coelicolor and Streptomyces avermitilis. Its formal deposition into the NRRL culture collection provided a stable reference for subsequent scientific and industrial study.
On solid media such as International Streptomyces Project agar, the strain exhibits typical Streptomyces morphology, forming a compact, branching substrate mycelium. Upon maturation, it produces aerial hyphae that differentiate into long chains of grayish spores, contributing to the species epithet "griseus." The colony often secretes a characteristic pigment, which can range from yellow to brown, into the surrounding agar. These morphological traits are key identifiers in traditional bacteriological classification within the order Streptomycetales.
The strain is an obligate aerobe with a chemoorganotrophic metabolism, capable of utilizing a wide range of complex carbohydrates like starch and cellulose. Its primary historical significance lies in its secondary metabolism, specifically the biosynthesis of streptomycin, an aminoglycoside antibiotic. The biochemical pathway involves specialized enzymes that assemble the streptidine and streptose moieties. The strain also produces other secondary metabolites, including grisin and certain siderophores, under specific fermentation conditions developed at institutions like the University of Wisconsin–Madison.
NRRL 1951 served as the original industrial workhorse for streptomycin production, with fermentation processes optimized by companies like Pfizer and Bristol-Myers Squibb. Beyond antibiotic production, the strain and its derivatives have been used as a model system in metabolic engineering to enhance yield or produce novel analogs. Its enzymes are of interest in biocatalysis for the synthesis of chiral intermediates. Furthermore, studies on its regulatory networks have informed the industrial fermentation of other valuable compounds from related species like Streptomyces rimosus.
The complete genome sequence of related Streptomyces griseus strains reveals a large, linear chromosome rich in GC-content, typical of the genus. It harbors numerous gene clusters for secondary metabolite biosynthesis, including the well-characterized streptomycin cluster. Genetic studies, pioneered by researchers like David A. Hopwood at the John Innes Centre, have elucidated the complex regulatory cascades involving A-factor that control both morphological differentiation and antibiotic production. The strain's genetic tractability has made it a subject for studies on horizontal gene transfer and plasmid biology within actinomycetes.